NAD as Biomarker for Mitochondrial Disorders

About Nadmed

Nadmed is a Helsinki-based diagnostics company that has developed a proprietary, colorimetric method for precisely measuring all four NAD types and glutathione from minimal blood samples. Originating from research at the University of Helsinki, its CE-marked kits and lab services cater to clinical trials, research institutions, and diagnostic labs globally. The company is capitalizing on the growing scientific and commercial interest in NAD as a biomarker for aging, metabolic disorders, and neurodegenerative diseases, partnering with biotechs and CROs to integrate its testing into drug development and personalized health.

Therapeutic Areas